Stocks
Novo Nordisk (NVO) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 4.14 | 3.94 | 4.02 | 3.76 | 4.08 | -0.04 | ||
| Changes by years, y/y, % | +55% | -5% | +2% | -6% | +8% | +16.7% | |||
Novo Nordisk. EV/EBITDA
Novo Nordisk. EV/EBITDA, changes, %
Novo Nordisk (NVO) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EV/EBITDA | ? | 4.27 | 3.97 | -0.03 | 0.14 | -0.04 | -0.04 | |
| Changes by years, y/y, % | -4 410% | -2 868% | -101% | -97% | -101% | |||
| Changes by quarters, q/q, % | -7% | -101% | -612% | -130% | ||||
